Introduction

Ethnobotanical research on pharmaceutical remedies obtained from medicinal plants is continuously developing, thanks to the understanding of the therapeutic use of these plants and their importance in the historical, geographical, socio-cultural, anthropological and economic fields (Medeiros and De Albuquerque 2012; Reyes-García et al. 2006; Jarić et al. 2007; Thomas et al. 2009; Liu et al. 2009; de Albuquerque et al. 2007; Berihuete-Azorín 2013). The testimony of the use of medicinal plants and natural remedies dates back to ancient times. Most of the ancient populations were in close contact with the surrounding environment and from which they took the ingredients to produce remedies, medicines, drugs and products for body care and cosmetics (Jamshidi-Kia et al. 2018). The presence of hallucinogens and numerous other plants, such as aromatic ones (with a structure and chemical composition also similar to the brain hormones), explains the importance they had for medicine in different times and cultures, and the interest that all this has in the field of cultural anthropology. In this sense, the first writing that is an evidence of the use of medicinal plants for the remedy preparation was found on a Sumerian clay slab from Nagpur, dating back to about 5000 years ago (Jamshidi-Kia et al. 2018). The Nippur tablets, dated to the 3rd millennium BC, bring together the oldest known collection of medical prescriptions, closely followed by various ancient Egyptian texts including numerous references to mineral and vegetal therapy, such as the Ebers Papyrus, dated around at 1500 BC. In these ancient texts, the value and properties attributed to certain medicinal substances are linked to certain gods (Bilimoff 2003), aspects that are maintained over time and that we can still see in the Spezieria of Santa Maria della Scala in Rome, the object of this research. In China, for instance, a few dozen drugs extracted by plants or having an animal origin were already recorded around 1100 BC, while in ancient Greece, Hippocrates already discovered the properties of numerous plants in his treatise On Air, Water, and Places, considered the first book on geomedicine and the environment. In the Greco-Roman world, these descriptions were followed by those made by Theosophus of Ephesus (fourth and third century BC), Dioscorides (first century AD), Pliny the Elder (first century AD), Galen (fourth century AD) and Oribasio of Pérgamo (fourth and fifth centuries AD) in their respective treatises, among other authors. In fact, ancient Greek culture had the rizotómos, an expert in medicinal herbalism, and the pharmacopoeia, an expert in and seller of plant medicines (Rey 2008; Bennett and Prance 2000). Also in antiquity, but in other non-European cultures, the use of natural therapeutics, based on the properties of plants, was also of great importance, according to Ayurvedic medicine in India, and current healing practices among Australian Aborigines, African communities and American indigenous populations, based in all cases on the knowledge and use of ancient therapeutic remedies, which, again, reminds us of the importance that these studies and field of knowledge have for cultural anthropology. In other words, the use of drugs and psychotropic drugs is relevant in comparative cultural anthropology because the use of one or the other acquires meaning within each socio-cultural worldview, and this from the past to the present.

Returning to Europe, after the fall of the Western Roman Empire (476 AD) and the beginning of the Middle Ages, plant-based substances and formulations continued to have great importance in Western and Eastern Europe (Byzantium), and in both the Christian and Islamic world (Taylor 2016), as evidenced by the treatises of Mesue the Younger (1013), Avicenna (978-1036), Juan Serapion (1070) or Bartholomeus Anglicus (1220), among others. This was also projected in the Modern Era, and between the fifteenth and eighteenth centuries, natural medicine of plant and animal origin coexisted with the mineral. In this sense, it was not until the early Renaissance that hermetic philosophy and alchemy sought to provide a more rational explanation for the healing properties of plants and to explain the importance of mineral and vegetal compounds. The physician and alchemist Paracelsus (c. 1496) was the most outstanding example of scholars in this field. Paracelsus described how certain diseases could be cured with plants that resembled the organ that needed healing (Nitrihual Valdebenito 2015).

The mixtures of various vegetal species, or the mixture of these species with minerals and salts (as with theriac), are understood in alchemical philosophy to possess “body, soul and spirit”. In this context (i.e. under the influence of the new pharmaceutical science of Paracelsus), by combining the therapeutic heritage of numerous cultures from East and West (from the Sumerian of the ancient Near East to the Roman, passing through the Babylonian, Persian, Egyptian or Greek, among others), the friars of Santa Maria della Scala of Rome worked in this spezieria preparing drugs between the seventeenth and eighteenth centuries. Therefore, the pharmaceutical formulations that have been preserved here from those centuries, and that we have analysed, should show us this synthesis of substances and traditions from different times and cultures.

In the case of resins, it should not be forgotten that in many ancient cultures, they were interpreted as the vital liquid equivalent to human blood, which they could substitute in numerous rituals and practices.

The importance of these pharmaceutical remedies and cosmetic preparations from a historical, anthropological and social point of view has led to many investigations concerning these materials, also from a scientific point of view. In fact, the chemical investigation of these materials, generally found in ceramic, glass or stone containers, can provide exceptional information regarding both pharmaceutical and technological knowledge and the practices in their use (Ribechini et al. 2008, 2011a; Colombini et al. 2011).

In particular, the analyses related to the organic substances and mixtures appear to be of fundamental importance for identifying the materials, understanding their origin and their use and providing further information also related to everyday life. These are the topics of numerous investigations and works dealing with the characterisation of ancient cosmetics and archaeological residues (Riva 2001; Gamberini et al. 2011; Modugno et al. 2006; Izzo et al. 2013; Saliu et al. 2011; Petrović et al. 2005; Guasch-Jané et al. 2004; Lucero-Gómez et al. 2014; Mackonochie and Heinrich 2019).

In this research, we studied the organic composition of 8 ancient remedies and pharmaceutical formulations conserved in the cited Spezieria di Santa Maria della Scala in Rome, founded at the end of the seventeenth century by the religious order of the Discalced Carmelites, as previously indicated. As reported in Vázquez de Ágredos Pascual et al. (2018), these friars had the possibility to use vegetal substances and mineral resources from Central and South America, and different regions of India, China and Japan. The Order of Discalced Carmelites, a religious order of Spanish origin, during the seventeenth century controlled trade with the East and West Indies, and at the end of the seventeenth century, they founded the Spezieria di Santa Maria della Scala inside their convent in Rome. In particular, the friars were known to use and mix organic compounds (especially from botanical sources) for their pharmaceutical preparations, in accordance with the most important pharmacopoeias from the post-Constantine period, such as Antidotarium Nicolai. From the West Indies, for example, came products such as jalap, guaiacum, hydrastis, ipecacuanha, rathany root and sarsaparilla. For its part, the glass and wooden containers in which the compound drugs and simple substances are preserved at Santa Maria della Scala of Rome mention some of these plant species of American origin, including the guaiacum (Guaiacum officinale L./G. Sanctum L.) or guayacan, palo santo (holy stick) or Indian stick (Bursera graveolens), ipecacuanha root (Carapichea ipecacuanha (Brot.) L. Andersson), coca extract (Erythroxylum coca) and tobacco (Nicotina tabacum).

A first attempt to disclose the composition of un unknown drug formulation from the Spezieria was recently published by Lodi et al. (2020), but further investigations were required in the study of the origin and use of the medicines that have remained inside the containers in the Spezieria for centuries.

However, specific scientific literature provides very limited analytical studies of Modern Age pharmaceutical remedies and drugs. For this reason, this research, and the scientific results it offers, should be considered one of the few contributions to the physicochemical study of medicines prepared with organic compounds in the Modern Age, characterised by being in themselves a melting pot among the ancient therapeutic traditions and the new pharmaceutical science after Paracelsus (Medeiros and De Albuquerque 2012; Brandão et al. 2008).

The new way of treating diseases from Paracelsus, and especially between the Renaissance and the Baroque, is also associated with beliefs linked to a very particular worldview of the drug, deeply rooted in alchemy. In this sense, it was Paracelsus who masterfully incorporated the chemical or al-kémicas laws into the medical or iatrochemical (iatros = medicine) environment while also maintaining all their hermeticism. To do so, he had to carry the alchemical laws to the field of pharmacological medicine under a generic term, spagyric, which he revamped and used to describe “hermetic medicine” and the preparation of the therapeutic remedies that derived from it. Then, between the fifteenth and eighteenth centuries, the practice of preparing certain complex formulations for healing was connected not only to scientific principles, but also to others associated with magical thinking, of great interest to cultural anthropology.

The ancient Spezieria of Santa Maria della Scala in Rome, thus, offers an extraordinary opportunity to widen this knowledge. For this purpose, the present study took into consideration several remedies and pharmaceutical formulations preserved in the main showcase of this historical pharmacy, organic materials used, since ancient times, to prepare incense, medicines, cosmetics and perfumes.

These compounds were analysed by gas chromatography coupled with mass spectrometry (GC-MS) since this technique allows the separation and the identification of organic fractions present in complex organic mixtures by solving the molecular composition of organic materials and their degradation products. Organic fractions are also called biomaterials and are mainly lipids, proteins, vegetable resins, polysaccharides, organic dyes and a variety of plant extracts that have been the main components of cosmetics and pharmaceutical products since ancient times. They consist of complex mixtures of many chemical species, with a wide range of molecular weights, from highly volatile monoterpenes and sesquiterpenes to highly insoluble macromolecules, such as denatured proteins or highly polymerized resins (such as amber). The chemical composition of natural organic materials varies according to the species of animal or vegetable origin, and this complexity increases because often we are faced with their transformation products, mainly due to ageing (Mills and White 1994; Colombini and Modugno 2009).

In Archaeology and Heritage Science, GC-MS identification is often based on the detection of diagnostic molecules named biomarkers. These biomarkers are present intact in the original material, or they are formed over the centuries due to ageing (Colombini et al. 2005). The characteristic biomarkers of the extant species are still recognizable in their fossil counterparts (Simoneit et al. 2016)

In literature, there are several articles on the characterisation of historical organic materials that use this approach, in particular related to the study of ancient cosmetics (Ribechini et al. 2011a; Pérez-Arantegui et al. 2009; Gamberini et al. 2008), of residues found inside an ancient Etruscan plumpekanne (Mizzoni and Cesaro 2007; Colombini et al. 2009) or related to the characterisation of organic components of the original contents of Egyptian ceramic vessels (e.g. natural resins, waxes, bitumen, pitch and lipid materials) (Colombini et al. 2005; Ribechini et al. 2009) or of seven Roman glass unguentaria (Ribechini et al. 2008). Moreover, GC-MS was also employed to characterise and compare the composition of modern and archaeological figs (Ribechini et al. 2011b), historical honey (Oliveira et al. 2019), mummies (Abdel-Maksoud et al. 2019) and dental calculus (Gismondi et al. 2020).

Finally, the study of historical drugs that are preserved in the Spezieria of Santa Maria della Scala in Rome, visited by Popes, the European royalty and nobility of the seventeenth and eighteenth centuries, is not only important to know the practices handed down by apothecaries in the past, but also fundamental to reconstruct historical recipes that can inspire new dermatological, cosmetic, hygienic and current curative products. The complex pharmaceutical formulations, thus, provide a way of knowledge towards the medical science of the past, with keys to the innovation in many pharmaceutical laboratories today.

Materials and methods

Analysed compounds

The selection of the organic compounds to be analysed was based on previous results by Vázquez de Ágredos Pascual et al. (2017, 2018) obtained by XRD, Raman and FT-IR. They suggested the creation of 7 distinct groups of drugs and pharmaceutical remedies, one mainly characterised by the presence of organic compounds. Organic substances, thus, represent a larger part of the remedies and the pharmaceutical formulations stored in the main showcase of the Antica Spezieria di Santa Maria della Scala in Rome (Fig. 1).

Fig. 1
figure 1

Spezieria di Santa Maria della Scala salesroom, main showcase and better "glass containers" (no jars)

It is interesting to notice that several compounds in group 5 “organic compounds” had both artistic and medicinal uses.

Table 1 reports the list of the organic samples analysed in this paper and their description. These compounds were stored in the main showcase of the salesroom, into sealed containers. The labels reporting their names are partially missing or not clearly readable. They suggest the presence of vegetal resins and balsams.

Table 1 List of the analysed samples with the names reported in the labels and their description

In Table 1, a brief description of the samples and the images obtained by optical microscopy are reported as well.

GC-MS

Based on previous results (Vázquez de Ágredos Pascual et al. 2017, 2018), the GC-MS analyses were focused on the identification of natural resins and balsams in the selected drug formulations. A quaternary ammonium salt, namely m(trifluoromethylphenyl)trimethylammonium hydroxide, 0.2 N methanolic solution, was chosen since its capability of transesterifying triglycerides, wax esters, phospholipids, steryl esters and etc. and transforming them into their corresponding methyl esters. Small amounts of sample (up to 0.35 mg) were transesterified by a one-step process using 30 μL of m-(trifluoromethyl)phenyltrimethylammonium hydroxide, 2.5% in methanol, and then 1 μL of the derivatised sample was injected in the chromatographic column’s head using helium as the carrier gas (flow rate 1.2 mL/min, 99.99% purity). This method was already successfully tested by authors already on archaeological pitch (Izzo et al. 2013), fatty acids from historical and modern drying and non-drying oils (Fuster-López et al. 2016; Izzo et al. 2014a, b; Fuster-López et al. 2019; Caravá et al. 2020), natural waxes and terpenic resinaceous materials from artistic and archaeological contexts (Izzo et al. 2013, 2017; Rigon et al. 2020), an unknown historical drug formulation from this Spezieria (Lodi et al. 2020).

The GC-MS runs were performed on an Agilent Technologies 6890N (Network GC System) equipped with a mass spectrometric detector Agilent 5973 with a quadrupole analyser. The chromatographic separation was performed on a chemically bonded fused silica capillary DB – 5MS column (30 m length, 0.25 mm internal diameter, 0.25 μm film thickness of stationary phase – 5% phenyl methyl polysiloxane).

The GC and MS conditions were experimentally set up. The inlet temperature was 290 °C, and the MS interface was at 250 °C. The temperature program was set from 100 to 320 °C with a ramp of 10 °C/min, and held the temperature for 15 min. The analyses were run using a split injector.

Being untargeted analysis, the MS was run in full scan mode (m/z 50–650), 1.9 scans/s.

Solvent delay was set at 4.5 min. The transfer line was at 240 °C and the source temperature was 230 °C. Electron ionisation energy was 70 eV.

The compounds were identified by the use of the NIST and MS Search 1.7 Library of Mass Spectra, but since commercial MS libraries do not generally include the compounds analysed in this study, MS interpretation and a library created by the authors for natural materials using AMDIS (Automated Mass spectral Deconvolution and Identification System) software were employed as well.

Results and discussion

Table 2 reports the results obtained by GC-MS analysis. As it can be observed, the samples are characterised by fairly/very complex mixtures of organic compounds. The complexity of the results is reflected in the difficulty in assigning some substances. In fact, the name on the label could not always be used as a key for reading and interpreting the data obtained. In some cases, the label was even absent; in others, no correspondence was found between the reported name and the data obtained. Furthermore, although some of these substances were also used in the artistic field, their use in the pharmacological field has not been completely codified.

Table 2 List of the samples, results obtained and GC-MS analysis after transesterification (“ME” stands for methyl esters, “diME” stands for di-methyl esters). The compounds in bold are those more abundant in the chromatograms

Of all the samples analysed, five emblematic examples of pharmaceutical remedies are discussed below, given their particular compositions.

The names of the samples are listed below: LS81 benzoin (the “Sample LS81 benzoin” section), LS119 Resina Guajac and LS193 guaiacol resin (the “LS119 Resina Guajac and LS193 guaiacol resin” section), LS171 unlabelled (the “Samples LS 171 unlabelled” section), LS232 resin scamon and LS223 Ladon (treated in the “LS232 resin scamon and LS223 Ladon” section as complex mixtures), LS142 Babam odintalg and LS174 Balsam S.Ton (treated in the “LS174 Balsam S.Ton and LS142 Babam odintalg” section as aromatic substances).

Sample LS81 benzoin

The sample analysed through GC-MS presents an interesting chromatographic profile (Fig. 2). As reported in Table 2, mainly oxidised and non-oxidised phenolic compounds and volatile compounds have been identified.

Fig. 2
figure 2

TIC chromatogram of sample LS81 after transesterification and GC-MS analysis. Peak 1 = benzaldehyde, 4-methoxy; 2 = benzoic acid, 4-methoxy–diME; 3 = cinnamic acid ME; 4 = vanillin methyl ether (veratric aldehyde); 5 = terephthalic acid diME; 6 = toluene; 7 = benzene, 4-dimethoxymethyl-1, 2-dimethoxy; 8 = veratric acid ME; 9 = tridecanoic acid ME

More precisely, GC-MS analyses revealed the presence of aromatic methyl esters (cinnamic acid and oxidised benzoic acid, marked with numbers 3 and 2 respectively in Fig. 2), with their corresponding aromatic acids, methoxy-benzaldehyde (peak 1), toluene (peak 6) and fatty acid (peak 9).

Cinnamic acid and benzoic acid are the main components of two phenolic resins: benzoin resin (Styrax genus) or storax/styrax resin (Liquidambar genus).

The term styrax has generated a fairly frequent nomenclatural confusion in resin terminology, so much so that Liquidambar gums (Hamamelidaceae) are often marketed as benzoin but should not be considered such from a botanical and chemical point of view (Hovaneissian et al. 2006; Langenheim 2013).

The presence of vanillin methyl ether (peak 4) was also revealed, which is crucial for the distinction between benzoin resin (in which it is present) and storax resin (in which it is absent) (Modugno et al. 2006). Furthermore, by analysing a historical drug, we must take into account the possible degradation of the compounds. In fact, vanillin, being an aldehyde, is not a very stable compound by nature, and it easily oxidises in its corresponding acid: veratric acid (also detected as methyl ester, marked with peak number 8).

Hovaneissian et al. (2008) report that the storax resin obtained from the Turkish species (Liquidambar) contains isovanillin in very smaller amounts than cinnamic acid and benzoic acid. As reported in literature, methoxy-benzaldehyde (1) was detected in ancient samples of benzoin resin and not in those of storax resin (Modugno et al. 2006). Castel et al. (2006) find the presence of toluene as a volatile constituent of the benzoin resin. In this case, the sample LS81 was in a sealed jar, so volatile compounds such as toluene (peak 6) may not have evaporated.

In light of the results obtained by analytical technique, it can be stated that the sample under examination is indeed benzoin resin and not styrax resin.

Benzoin resin, in fact, is a balsamic resin of rather hard consistency whose main components are not terpenes but aromatic esters (benzoic acid and cinnamic acid) with their corresponding aromatic acids. The amount of these compounds is very variable and depends on the resin species from which they are obtained. It comes from the Styrax genus, from the Stryraceae family (Mills and White 1994; Neamsuvan et al. 2012). Moreover, the label quoted the name “benzoin” and the hardness of the sample immediately suggest a connection with the benzoin resin.

Benzoin resin was traditionally used in medicine, cosmetics, perfumery and ritual ceremonies along with myrrh (Commiphora myrrha) or olibanum (Boswellia thurifera; Boswellia sacra) for its characteristic odoriferous properties. In the Mediterranean region, it was already known by the Ancient Greeks: It is in fact mentioned by Herodotus (fifth century AD) and Theophrastus (fourth and third century AD) and is recommended by Hippocrates (fifth and fourth century AD) as a remedy (Langenheim 2013). However, the first report which unequivocally refers to this resin comes from the fourteenth century Arab traveller Ibn Batuta. It was suggested that the Arabic name luban djawi (frankincense of Java) was later changed to banjawi to finally give benjoin or benzoin. The only representative of the Styracaceae in the Mediterranean and native to Cyprus is Styrax officinalis (Meikle 1977/1985), the source of solid storax. Interestingly, both dioscorides and Pluny in writing about styrax mentioned that the product comes not only from places now in southeastern Turkey, western Syria or Lebanon but also from Cyprus and Crete (Lardos et al. 2011).

Table 3 summarises (some of) the uses and pharmacological functions of benzoin resin as a medicament, ranging from anti-inflammatory agent to filling for a skull fracture.

Table 3 Uses and provenance of the studied drugs

In the artistic field, benzoin resin has been used since the sixteenth century as a painting coating (especially for wooden supports). Thanks to its film-forming properties, it was used both alone and in a mixture with shellac to give better polish and smoothness to the polishing effect (Beninatto and De Lucchi 2016).

LS119 Resina Guajac and LS193 guaiacol resin

Reddish-brown small fragments, partially translucent, and slightly sticky, constituted these samples.

The preliminary study conducted by FT-IR spectroscopy showed very similar IR spectra. After analysing the samples via GC-MS, we had further confirmation of the similarity between the samples and for this reason, we decided to show only one of the chromatograms (reported in Fig. 3).

Fig. 3
figure 3

TIC chromatogram of sample LS 193 after transesterification and GC-MS analysis. Peak * = p-ethylguaiacol; 1 = vanillin methyl ether (veratric aldehyde); 2 = propenyl guaiacol; 3 = dimethoxy benzoic acid ME; 4 = palmitic acid ME; 5 = oleic acid ME; 6 = stearic acid ME; 7 = guaiaretic acid (galbulin); 8 = benezene,1,2-dimethoxy; 9 = guaiaconic acid (galgravin)

Among the compounds identified by GC-MS, the characteristic components of guaiac resin have been detected: guaiacol derivatives (marked with * and number 2), vanillin (peak 1), guaiaretic acid (called also galbulin, peak number 7) and guaiaconic acid (galgravin, peak number 9), whose structures are shown in Fig. 4.

Fig. 4
figure 4

Structures of main compounds present in Guajacum resin

It is possible to state that these two pharmaceutical remedies, contained in different jars, mainly contain guaiacum resin. As reported in the literature, the resin extract from (Guaiacum officinale L./G. Sanctum L.) (Fam. Zygophyllaceae, a plant native to Central America and the Caribbean, mainly from Costa Rica, Jamaica, Dominican Republic, Cuba and Brazil) is a complex mixture containing approximately 70% alpha- and beta-guaiaconic acids, 10% guaiaretic acid and 15% guaiac beta-resin; additionally, guaiac yellow and vanillin are present (Haworth et al. 1934).

Furthermore, the name reported on their labels permits to hypothesise that these compounds may derive from the guaiacum, a Zygophyllaceae timber (Guaiacum sanctum L. or G. officinale L.), whose resin is generally called gum guaiac or resin Guajac (Kratochvil et al. 1971; Medeiros and De Albuquerque 2012; Brandão et al. 2008).

The presence of some fatty acids, in particular palmitic acid, oleic acid and stearic acid (peaks marked with numbers 4, 5 and 6 respectively), can be explained by their use as a vehicle for taking the remedy: Indeed, a vegetable oil might have been employed. The presence in a high amount of oleic acid suggests that the oxidation of the organic material did not completely occur; this may be related to the closure of the jars: It was probably so well sealed that slowed the oxidation processes.

About the use of guaiacum resin, the historical research reports many medical and pharmacological applications, for instance, its use in the form of a decoction to treat chronic gouty affections (Munger 1949; Corp and Pendry 2013) and rheumatism (Kratochvil et al. 1971). In addition, guaiac wood (lignum sanctum) has also been used to treat diseases, for example syphilis (Vargová et al. 2019).

Samples LS 171 unlabelled

Figure 5 depicts the chromatogram obtained from sample LS171 after transesterification and GC-MS analysis.

Fig. 5
figure 5

TIC chromatogram of LS171 sample after transesterification and GC-MS analysis. Peak 1 = decanoic acid ME; 2 = dodecanoic acid ME; 3 = cinnamic acid ME; 4 = epimanool; 5 = larixol acetate; 6 = larixol; 7 = isopimaric acid ME; 8 = dehydroabietic ME; 9 = beta-amyrin; 10 = lupeol acetate; 11 = alpha-amyrin

GC-MS evidenced a high heterogeneity in the composition of the pharmaceutical preparation, although the identified compounds mainly consist of materials of vegetable origin.

The presence of monocarboxylic acids, i.e. decanoic and dodecanoic acids (peaks 1 and 2), is visible in the first part of the chromatogram (lower molecular weights).

During the identification by GC-MS, the presence of characteristic diterpene biomarkers made it possible to evaluate the presence of pine resin. In fact, the simultaneous presence of neutral labdane compounds or rather epimanool (peak 4), larixol acetate (peak 5) and larixol (peak 6) (whose structures are reported in Fig. 6) emphasizes that material contains a semi-liquid resin extracted from Larix decidua, in particular Venice turpentine (also known as larch turpentine) (Mills and White 1994; Mazzei et al. 2020).

Fig. 6
figure 6

Structures of the main compounds present in sample LS171

Furthermore, isopimaric acid (peak 7) and dehydroabietic acid (peak 8) were detected. This evidence permits to advance the hypothesis that the material contains a resin obtained by distilling a piece of wood from the Pinaceae family (Mills and White 1994). Dehydroabietic acid is present in fresh resins, but its concentration tends to increase over time. In ancient resins, in fact, the volatile fraction decreases while the percentage of diterpenes increases: Dehydroabietic acid is present in large quantities in ancient resins as a degradation product of abietadienic acids, easily degradable due to a conjugated double bond (Mills and White 1994) marker of a Pinaceae resin as well, even if aged.

Furthermore, pentacyclic triterpenes were detected as well, namely alpha /beta-amyrin (peaks 11 and 9 respectively) and lupeol acetate (peak 10 of Fig. 6). Moreover, the experimental evidence combined with historical research and the botanical composition has allowed us to formulate a hypothesis regarding the co-presence of these triterpene compounds: It could be the exudate of a plant from South America, most likely a copal (Merali et al. 2018). This hypothesis can be sustained by the fact that friars controlled the trade route with the West Indies (da Cruz Albino et al. 2020).

Taking into account the results obtained from this cross-investigation, it can be hypothesised that the LS171 sample is a mixture of saturated fatty acids which act as carriers and/or reduce the viscosity of an oleoresin from the larch (Venetian turpentine), a pine resin (Pinaceae family) and an exudate from a plant of South American origin.

This complex mixture could have been used as an ointment with an anti-inflammatory purpose since the steroid structures often determine this property (Figueroa-Suárez et al. 2019). Moreover, the cinnamic skeleton is interesting for the development of new antimicrobials; however, its antimicrobial mechanism of action is little known (Guzman 2014).

LS232 resin scamon and LS223 Ladon

GC-MS results highlighted extremely complex mixtures. The sample LS232 seems to be a mixture of scammony resin, fatty acids (vegetable oil with unsaturation) and fatty alcohols (all compounds identified are listed in Table 2).

On the other hand, LS223 sample is a very complex mixture of “ladano” resin, a characteristic marker of Venetian turpentine (larixol), and fatty acids.

GC-MS analyses revealed the characteristic compounds of scammony resin (peaks number 2 and 5). According to the literature, rhamnopyranosyl (peak 2) and glucopyranoside (peak 5) appear to be the constituents of scammonic acid, a glucosidic acid which is one of the main components of scammony resin (Fig. 7) (Noda et al. 1990).

Fig. 7
figure 7

TIC chromatogram of LS232 sample after transesterification and GC-MS analysis. Peak 1 = corynathin; 2 = rhamnopyranosyl; 3 = capric acid ME; 4 = hydroquinone; 5 = glucopyranoside; 6 = dimethoxy-cinnamic acid ME; 7 = palmitic acid ME; 8 = oleic acid ME; 9 = dehydroabietic acid ME

Moreover, the name reported on the label “resin scamon” may refer to the scammony resin, also called resin scammonium, an extract of the root of Convolvulus scammonia L., a plant original of the eastern Mediterranean and some Near East places, such as Crimea, Caucasus, Turkey, Syria, Greece and Iran. Historically this plant was known by Hippocrates (around 400 BC) and Theophrastus (around 300 BC) for its purgative and cholagogic action (Langenheim 2013; De Vos 2010).

As mentioned above, fatty acids (in this case, capric acid (peak 3), pentadecanoic acid, myristic acid, palmitic acid (peak 6), oleic acid (peak 8), linoleic acid, dimethyl-undecanoic acid and tridecanoic acid were detected) are probably present as carries and as agent reducing the viscosity of the extract. Fatty alcohols (such as hexadecanol and myristic alcohol) could be used as emollients, emulsifiers or thickening agents. Corynathin (peak 1) is a typical alkaloid of Amsonia Elliptica brevifolia (Sauerwein and Shimimoura 1990); the hydroquinone (peak 4) (as cinnamic acid) instead is a phenol normally present in plant families; for this reason, we cannot consider it a characteristic biomarker. Finally, dehydroabietic acid (peak 9) can be present as a maker of pine resin or as a degradation product of abietadiene acids.

The compounds identified within the LS223 sample by GC-MS analysis are shown in Table 2.

Figure 8 depicts the chromatogram of sample LS223, sclareolide and manoyloxide (marked with 1* and 2*’) which are the main components of resin ladan, an exudate of Cistus creticus, a plant that grows in Greece, more precisely on the island of Crete (Demetzos et al. 1994). From historical research, it seems that the name “Ladon” written on the LS223 sample label may also refer to “ladan” resin. Folk medicine used this resin to treat various diseases (Demetzos et al. 1994)—e.g. abdominal pain (Rivera et al. 2019)—and in the cosmetic industry to create perfumes (Mackonochie and Heinrich 2019). From the Greeks, many of its properties were attributed by the association of the name, Ladon, to the mythological account. In Greek mythology, this was the name of the hundred-headed dragon in charge of guarding the garden of the Hesperides with the help of some nymphs (Graves 1992). All the Cistus species are frequently used in many traditional medicines for their antimicrobial, antitumor, antiviral and anti-inflammatory properties (Bouamama et al. 2006).

Fig. 8
figure 8

TIC chromatogram of LS223 sample after transesterification and GC-MS analysis. Peak 1* = sclareolide; 2*’ = manoyloxide; 3 = larixol

Larixol (peak 3) and fatty acids (myristic acid, pentadecanoic acid, palmitic acid, stearic acid and arachidic acid) were also identified. The first is a neutral labdane diterpene, a characteristic marker of Venetian turpentine.

LS174 Balsam S.Ton and LS142 Babam odintalg

In this section, aromatic substances are discussed.

GC-MS analyses on LS174 sample revealed a fairly complex mixture of balsamic compounds (monoterpenes and sesquiterpene of essential oils), whose chromatogram is shown in Fig. 9. As reported in Table 2, monoterpenes (camphor, borneol, endoborneol), benzyl alcohol, cedrol and geranic acid were detected.

Fig. 9
figure 9

TIC chromatogram of LS174 sample after transesterification and GC-MS analysis. Peak 1 = camphor; 2 = borneol; 3 = benzyl alcohol; 4 = cedrol (cedrolie); 5 = geranic acid ME; 6 = endoborneol

As reported in the literature, cedrol (peak 4) could be detected in the essential oil of conifers, especially in Cupressaceae and Juniperaceae genera (Hosseinihashemi et al. 2017; Fadel et al. 2019). Camphor (peak 1), borneol (peak 2) and endoborneol (peak 6) are bicyclic monoterpenes: The first one is obtained by steam distillation from the wood of the camphor tree, the Cinnamomum camphora. This is one of the oldest herbal medicines used as a traditional medicine, owning a wide range of biological functions, including antibacterial, antioxidative, anti-fungal, anti-inflammatory, insecticidal and repellent activities (Chen et al. 2020). The other monoterpenes are normally present in essential oils with benzyl alcohol (peak 3) and geranic acid (peak 5) (Beninatto and De Lucchi 2016).

The compounds identified within the LS142 sample are displayed in Table 2. This is a complex mixture of balsamic compounds, terpene compounds and fatty acids.

Cadinene (peak 1) and junicedric acid (peak 11) methyl ester could be present not only in the juniper essential oil (Juniperus oxycedrus L.) (Duane and Thomas 1991), but also in the Araucaria araucana, a plant of Argentine origin that was used for the treatment of bruises and ulcers and as a wound-healing agent (Fig. 10) (Shahzad Aslam et al. 2013).

Fig. 10
figure 10

TIC chromatogram of LS142 sample after transesterification and GC-MS analysis. Peak 1 = cadinene; 2 = cinnamic acid ME; 3 = vanillin methyl ether (veratric aldehyde); 4 = patchoulol; 5 = veratric acid ME; 6 = methylmethoxy cinnamate; 7 = palmitic acid ME; 8 = oleic acid ME; 9 = stearic acid ME; 10 = dehydroabietic acid ME; 11 = junicedric acid ME

Methyl esters of phenol-carboxylic acids (benzoic and cinnamic acid (peak 2) and their derivatives identified can be interpreted as constituents of many species of the plant kingdom (plants, dried fruit). Moreover, patchoulol (peak 4) was detected. As reported in literature, it is one of the main compounds of patchouli essential oil (Verma et al. 2019; Kusuma and Mahfud 2017). Also in this case, fatty acids, such as palmitic, oleic and stearic acids ME (peaks 7, 8, 9 respectively), were detected; in all probability, they have the function of carriers. Dehydroabietic acid methyl ester was also identified (peak 10). As reported above, it is a fresh resin constituent and in ancient resins, it can be present as a degradation product of abietadienic acids, easily degradable due to a conjugated double bond (Mills and White 1994).

Uses and provenance of the studied drugs

This section presents a summary table that affects some of the samples studied and the connection between the composition of the drug and the names reported on the jars.

In general, it can be said that many resins and oleoresins have antiseptic, anti-inflammatory and antibacterial properties and are used in cosmetics or as perfumes or in incense (Mackonochie and Heinrich 2019).

Conclusions and further perspectives

The chemical investigation by GC-MS has successfully identified the organic materials preserved in selected historical remedies and pharmaceutical formulations from the Spezieria di Santa Maria della Scala in Rome. They resulted to be complex mixtures containing several vegetal resins, balsams and fatty acids.

Natural resins have been used as ointments with anti-inflammatory, antiseptic and antibacterial properties. These historical drugs were used in cosmetics, perfumes and incenses. Many of them were exudates of plants imported and it is assumed that they could have been used in a mixture according to ancient recipes. The phenol-carboxylic acids identified (benzoic and cinnamic acid and their derivatives) can be interpreted as constituents of many species of the plant kingdom (plants, dried fruit). The presence of some fatty acids (e.g. lauric acid, capric acid, palmitic acid, oleic acid, stearic acid) may be explained by the use of oils as carriers to take the remedy and/or to reduce the viscosity of the conditioner and as a base for mixing more “exotic” ingredients.

The analytical challenge for the study of the chemical composition of the remedies, combined with historical and botanical research, allowed to formulate compositional hypotheses of ancient medicines. The chemical investigation of the substances preserved in ancient “spezieries and apothecaries” is helping to substantiate the presence and provenance of many pharmaceutical drugs of ancient origin that were still in use in the Middle Ages and the Modern Era, as we have been able to verify in this study. Several of the drugs discussed here are complex formulations that include organic substances from America (guaiacum resin), Near East (scammony resin) or products of great importance in Islamic medicine, such as benzoin. The physicochemical identification, on the other hand, of aromatic compounds associated with these complex formulations, confirms the importance that fragrance had in the preparation of compounds that had to be ingested, whether or not they had other therapeutic properties.

This study of historical drugs is important also to deepen the knowledge of the practices handed down by apothecaries in the past, and also to reconstruct historical recipes that can inspire new dermatological, cosmetic, hygienic and current curative products, as occurs in laboratories of great recognition today, such as Aboca Coop. Agricola in Italy or L'Oreal in France.

Historical sources and analytical results allowed to confirm and provide a wide database which helps to identify trends in the continuous use of pharmaceutical drugs and medicinal practices from ancient cultures in Mediaeval, Modern and Baroque Europe. Even more, the deities, myths and beliefs of antiquity like the one that has been commented for the case of Ladon (sample L223), which substantiated the formula of many of these drugs, on which their therapeutic efficacy was often based, also found their way into the mediaeval and modern European pharmacopoeias (Junius 1985), used by the friars of the Roman Spezieria di Santa Maria della Scala. In the Middle Ages, a distinction began to be made between the more highly cultured or official medical knowledge practised by doctors and apothecaries and the popular wisdom handed down to modern times through oral tradition and ethnobotany and mainly imparted by women, usually associated with the practice of magic and sorcery (Maderna 2012). Despite all this, until recently, the history of the drug as a crucial part in the history of religions and comparative cultural anthropology was a pending chapter (Escohotado 1999). And yet, any of these plant substances, analysed from both disciplinary areas, allows to deepen the worldview of societies and cultures over time, and consequently understand highly precise and significant ritual, social practices and aspects of daily life. This category includes most of the resins considered in this research, such as resin scamon (L232), as it shows the iatrosophia (ιατροσóϕια), literally medical wisdom, and other substances from the plant kingdom, such as flowers, also present in Santa Maria della Scala, Rome, and the object of future studies.

The analytical information gathered in this study, thus, is an important resource for the knowledge of historical drug formulations and answers questions that, until now and to the best of our knowledge, had remained partially unresolved. In addition, this study will implement some of the projects carried out by the universities involved in this research, dedicated to the dissemination of the importance of knowing in a tangible and intangible way the ancient cultures and their historical sites (Lobovikov Katz et al. 2014; Vázquez de Ágredos Pascual et al. 2019).